Effects of Angiotensin II Receptor Blocker Compared With Diuretics in High-risk Hypertensive Patients (CHIEF)

This study is currently recruiting participants.

Verified August 2012 by Cardiovascular Institute & Fuwai Hospital

Sponsor:

Information provided by (Responsible Party):

Ma Liyuan, Cardiovascular Institute & Fuwai Hospital

ClinicalTrials.gov Identifier:

NCT01011660

First received: November 10, 2009

Last updated: August 9, 2012

Last verified: August 2012

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	December 2012
Estimated Primary Completion Date:	August 2012 (Final data collection date for primary outcome measure)

No publications provided by Cardiovascular Institute & Fuwai Hospital

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Ma L, Wang W, Zhao Y, Zhang Y, Deng Q, Liu M, Sun H, Wang J, Liu L. Combination of amlodipine plus angiotensin receptor blocker or diuretics in high-risk hypertensive patients: a 96-week efficacy and safety study. Am J Cardiovasc Drugs. 2012 Apr 1;12(2):137-42. doi: 10.2165/11598110-000000000-00000.

To Top